Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Bioanalysis|December 18, 2013
PK of immunoconjugate anticancer agent CMD-193 in rats: ligand-binding assay approach to determine in vivo immunoconjugate stabilityAzher Hussain, Boris Gorovits, Mauricio Leal, et al.American Journal of Therapeutics|March 5, 2004
A Mathematical simulation to explain the coordinated functions of efflux and metabolism limiting the transport of anti-HIV agents across Caco-2 cellsJignesh Patel, Azher Hussain, Dhahanjay Pal, et al.Journal of Pharmaceutical Sciences|September 24, 2010
Controversy in the allometric application of fixed- versus varying-exponent models: a statistical and mathematical perspectiveHuadong Tang, Azher Hussain, Mauricio Leal, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 25, 2007
Interspecies prediction of human drug clearance based on scaling data from one or two animal speciesHuadong Tang, Azher Hussain, Mauricio Leal, et al.World Journal of Orthopedics|November 22, 2019
Low-velocity simultaneous bilateral femoral neck fracture following long-term antiepileptic therapy: A case reportMohammed Sadiq, Vikrant Kulkarni, Syed Azher Hussain, et al.Mabs|February 5, 2014
The effect of the neonatal Fc receptor on human IgG biodistribution in miceNancy Chen, Weirong Wang, Scott Fauty, et al.Clinical Pharmacokinetics|March 28, 2019
Population-Pharmacokinetic Modeling of Tildrakizumab (MK-3222), an Anti-Interleukin-23-p19 Monoclonal Antibody, in Healthy Volunteers and Subjects with PsoriasisPetra Jauslin, Pooja Kulkarni, Hanbin Li, et al.Lung|June 7, 2022
A Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of 3 Weeks of Orally Administered Gefapixant in Healthy Younger and Older AdultsJesse Nussbaum, Azher Hussain, Anthony Ford, et al.Clinical Pharmacology in Drug Development|May 5, 2022
Clinical Formulation Bridging of Gefapixant, a P2X3-Receptor Antagonist, for the Treatment of Chronic CoughPranav Gupta, Azher Hussain, Anthony P Ford, et al.Journal of Clinical Pharmacology|June 3, 2022
Effects of Renal Impairment on the Pharmacokinetics of Gefapixant, a P2X3 Receptor AntagonistJesse C Nussbaum, Azher Hussain, K Chris Min, et al.Pageof 3